TVTX Travere Therapeutics, Inc.

$66.50 -1.06%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Travere Therapeutics, Inc. (TVTX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $6.3 billion. Shares last traded at $66.50, near their 52-week high. Over the past year the stock is up 239.5%. Net profit margin is -7.4%, above the peer median of -8.9%. Revenue grew 110.5% year over year.

Market Cap

$6.3B

Shares Out

94.3M

EPS (TTM)

$-2.11

P/E Ratio

—

P/S Ratio

10.60

P/B Ratio

255.62

Dividend / Share

—

Dividend Yield

—

52-Week High

$68.00

52-Week Low

$19.48

Volume

67,810

Avg Vol (3m)

88,252.952

Performance

-1.50%

+6.01%

+44.10%

+143.77%

YTD

+68.31%

+239.55%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

61.33

SMA (50)

$60.27

SMA (200)

$42.24

Price vs SMA50

+10.33%

Price vs SMA200

+57.44%

ATR (14)

$2.63

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$591M

Net Income

$-43M

Gross Margin

98.6%

Operating Margin

-6.8%

Net Margin

-7.4%

Return on Equity

-177.2%

Return on Assets

-5.4%

Current Ratio

4.05

Debt / Equity

1.88

Revenue Growth (YoY)

+110.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.78	2026-08-04
Q1 2026	$-0.40	2026-05-04
FY 2025	$-0.29	2026-02-19
Q3 2025	$-0.32	2025-10-30
Q2 2026	$-0.61	2026-08-04
Q1 2026	$-0.47	2026-05-04

Full earnings history →

Pharmaceutical Preparations peers

TVTX vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

P/S vs peers

10.60 / 11.11 med

-5% discount

Net margin vs peers

-7.4% / -8.9% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.